Skip to content
Open access

lncRNA Gm10451 mediates β-cell functional impairment in type 1 diabetes through the miR-24-3p/G6PD axis

Sep 2026 · Endocrine · Vol 91 · 0 citations · 48 references
Medicine

TL;DR

Overexpression of Gm10451 suppressed G6PD, aggravated oxidative/ER stress and inflammation, inhibited insulin secretion and promoted β-cell apoptosis, representing a poteniall therapeutic target for diabetes-related β-cell dysfunction.

Abstract

Pancreatic β-cell dysfunction underlies type 1 diabetes mellitus (T1DM) progression. Previous study showed that lncRNA Gm10451 is upregulated by high glucose and contributes to β-cell impairment, but its mechanism remains unclear. Interactions among Gm10451, miR-24-3p, and G6PD were validated by dual-luciferase assay and Ago2-RNA immunoprecipitation (Ago2-RIP). Expression was measured by RT-qPCR and Western blot. β-cell functions were evaluated by glucose-stimulated insulin secretion (GSIS), CCK-8, TUNEL, ELISA, and hyperglycemic clamp in 30 mM glucose-treated MIN6 cell and STZ-treated C57BL/6 mice (Control injected with citrate buffer). Gm10451 was upregulated in diabetic models. Gm10451 acted as ceRNA to spomge miR-24-3p, which directly targeted G6PD. Overexpression of Gm10451 suppressed G6PD, aggravated oxidative/ER stress and inflammation, inhibited insulin secretion and promoted β-cell apoptosis. miR-24-3p mimic reversed these impairments. Gm10451 promotes β-cell dysfunction via the miR-24-3p/G6PD axis, representing a poteniall therapeutic target for diabetes-related β-cell dysfunction.

Read PDF

Similar papers

Open access Sep 2026

miR-483 deficiency promotes loss of pancreatic beta-cell identity and aberrant glucagon production under metabolic stress.

Pancreatic β-cell dedifferentiation is a pathological mechanism that contributes to β-cell dysfunction and loss during type 2 diabetes (T2D), but the underlying mechanisms remain incompletely understood. MicroRNAs (miRNAs) are key post-transcriptional regulators of cellular identity and function. We previously identifi...

Katy Matson, Aaron Macleod, Ellie Sempek et al. · 0 citations
Sep 2026

Clinical Significance of miR-3619-5p Expression in Patients with Type 2 Diabetes and Its Regulation of Pancreatic β-Cell Proliferation.

The core pathological feature of type 2 diabetes mellitus (T2DM) is pancreatic β-cell failure; therefore, the identification of effective circulating biomarkers and molecular targets that regulate pancreatic β-cell homeostasis is of significant practical importance. As key regulatory molecules of gene expression, miRNA...

Jia-Wen Xu, Yu-Lin Liu, Yao-Jun Wang · 0 citations
Open access Sep 2026

LncRNA NR2F1-AS1 serves as a diagnostic biomarker for diabetic peripheral neuropathy and promotes disease progression by regulating miR-150-5p.

NR2F1-AS1 serves as a potential non-invasive biomarker and promising therapeutic target for DPN by driving Schwann cell dysfunction via the NR2F1-AS1/miR-150-5p/TP53 axis.

Ya-Zhi Zhao, Shi-Ling Rong, Xiao-Ya Ren et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.